CTRE:NYE-CareTrust REIT Inc. (USD)

COMMON STOCK | REIT - Healthcare Facilities |

Last Closing

USD 28.53

Change

+0.47 (+1.67)%

Market Cap

USD 5.43B

Volume

2.60M

Analyst Target

USD 18.67
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

CareTrust REIT, Inc.'s ("CareTrust REIT" or the "Company") primary business consists of acquiring, financing, developing and owning real property to be leased to third-party tenants in the healthcare sector. As of March 31, 2024, the Company owned directly or through a joint venture and leased to independent operators, 228 skilled nursing facilities ("SNFs"), multi-service campuses, assisted living facilities ("ALFs") and independent living facilities ("ILFs") consisting of 24,189 operational beds and units located in 29 states with the highest concentration of properties by rental income located in California and Texas. As of March 31, 2024, the Company also had other real estate related investments consisting of one preferred equity investment, nine real estate secured loans receivable and four mezzanine loans receivable with a carrying value of $233.3 million.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-22 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

+3.60 (+2.51%)

USD 92.95B
VTR Ventas Inc

+1.48 (+2.22%)

USD 29.73B
DOC Healthpeak Properties Inc

+0.36 (+1.95%)

USD 13.10B
AHR American Healthcare REIT, Inc.

+0.59 (+1.99%)

USD 4.79B
NHI National Health Investors Inc

+2.01 (+2.70%)

USD 3.54B
LTC LTC Properties Inc

+0.55 (+1.55%)

USD 1.55B
DHC Diversified Healthcare Trust

+0.03 (+1.35%)

USD 0.60B
UHT Universal Health Realty Income..

+0.95 (+2.49%)

USD 0.58B
CHCT Community Healthcare Trust Inc

N/A

USD 0.45B
GMRE-PA Global Medical REIT Inc

+0.33 (+1.33%)

USD 0.40B

ETFs Containing CTRE

BOUT Innovator ETFs Trust - In.. 5.91 % 0.80 %

+0.63 (+2.53%)

USD 0.01B
FCII:CA Franklin ClearBridge Sust.. 5.08 % 0.00 %

+0.17 (+2.53%)

CAD 0.02B
DXN:CA Dynamic Active Global Inf.. 4.68 % 0.00 %

+0.10 (+2.53%)

CAD 0.03B
FOVL iShares Focused Value Fac.. 3.35 % 0.25 %

+1.78 (+2.53%)

USD 0.02B
HDLV 3.31 % 0.00 %

N/A

N/A
XLUY 3.00 % 0.00 %

N/A

N/A
TPHE Timothy Plan - Timothy Pl.. 1.74 % 0.00 %

+0.59 (+2.53%)

USD 0.03B
TPHD Timothy Plan High Dividen.. 1.73 % 0.00 %

+0.83 (+2.53%)

USD 0.26B
XSLV Invesco S&P SmallCap Low .. 1.23 % 0.25 %

+0.90 (+2.53%)

USD 0.28B
DIVA 1.07 % 1.00 %

N/A

N/A
FESM Fidelity Covington Trust 0.80 % 0.00 %

+0.68 (+2.53%)

USD 1.49B
ULOV:LSE 0.72 % 0.00 %

N/A

N/A
TPLE Timothy Plan - Timothy Pl.. 0.72 % 0.00 %

+0.61 (+2.53%)

USD 0.02B
TPLC Timothy Plan US Large/Mid.. 0.71 % 0.00 %

+1.06 (+2.53%)

USD 0.29B
MUMC-B:CA Manulife Multifactor U.S... 0.48 % 0.00 %

+1.44 (+2.53%)

CAD 0.05B
MUMC:CA Manulife Multifactor U.S... 0.47 % 0.55 %

+0.13 (+2.53%)

CAD 0.01B
CZA Invesco Zacks Mid-Cap ETF 0.00 % 0.65 %

+2.61 (+2.53%)

N/A
FVD First Trust Value Line® .. 0.00 % 0.70 %

+0.79 (+2.53%)

N/A
PSCF Invesco S&P SmallCap Fina.. 0.00 % 0.29 %

+1.37 (+2.53%)

USD 0.02B
INFR ClearBridge Sustainable I.. 0.00 % 0.47 %

+0.59 (+2.53%)

USD 9.49M
FTGU:F First Trust Global Funds .. 0.00 % 0.00 %

N/A

N/A
HSMV First Trust Horizon Manag.. 0.00 % 0.00 %

+0.72 (+2.53%)

USD 0.02B
BBSC JPMorgan BetaBuilders U.S.. 0.00 % 0.00 %

+1.49 (+2.53%)

USD 0.45B

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.47% 63% D 86% B+
Dividend Return 1.24% 36% F 54% F
Total Return 6.71% 56% F 87% B+
Trailing 12 Months  
Capital Gain 19.37% 63% D 89% A-
Dividend Return 6.26% 50% F 82% B
Total Return 25.63% 63% D 90% A-
Trailing 5 Years  
Capital Gain 87.82% 86% B+ 73% C
Dividend Return 38.28% 71% C- 79% B-
Total Return 126.10% 86% B+ 77% C+
Average Annual (5 Year Horizon)  
Capital Gain 10.38% 73% C 69% C-
Dividend Return 15.71% 87% B+ 76% C+
Total Return 5.33% 53% F 84% B
Risk Return Profile  
Volatility (Standard Deviation) 20.31% 60% D- 50% F
Risk Adjusted Return 77.34% 87% B+ 85% B
Market Capitalization 5.43B 73% C 80% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.